Molecular Mechanisms, Pathways and Inhibition of Acetyl-Transfer Reactions
乙酰基转移反应的分子机制、途径和抑制
基本信息
- 批准号:10651689
- 负责人:
- 金额:$ 57.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATP Citrate (pro-S)-LyaseAcetate-CoA LigaseAcetyl Coenzyme AAcetylationAcetyltransferaseAnabolismBiologicalBiologyCardiovascular DiseasesCholesterolChromatinCytidineEnzymesFamily memberFatty AcidsFatty-acid synthaseHistonesHumanLifeLinkLysineMalignant NeoplasmsMediatingMetabolicMetabolismModificationMolecularN-terminalNerve DegenerationOrganismPathway interactionsPlayPositioning AttributeProtein AcetylationProtein Complex SubunitProteinsProteomeRNAReactionRegulationRibosomesRoleSideStimulusSubstrate SpecificitySyndromeTertiary Protein Structureamino groupbasecofactorgenetic regulatory proteinhistone acetyltransferasehuman diseaseinhibitorinhibitor therapyisoprenoidmetabolomepharmacologicrare genetic disordertargeted agenttargeted treatment
项目摘要
The acetylation of proteins and RNA, and acetyl-transfer reactions that produce cellular metabolites, are
evolutionarily conserved modifications that are essential for life. The post- or co-translational acetylation of
proteins provides an essential mechanism for organisms to react to external and internal stimuli; examples
include acetylation of the e-amino group of lysine side chains of histone proteins by histone
acetyltransferases (HATs) or the N-terminal a-amino group by N-terminal acetyltransferases (NATs),
respectively; and the acetylation at the N4 position of cytidine bases by Nat10. Acetyl-transfer reactions
produce cellular metabolites that can mediate the biosynthesis of essential cellular building blocks;
examples include: acetyl-CoA produced by ATP-citrate lyase (ACLY) and acetyl-CoA synthetase short-
chain family member 2 (ACSS2); fatty acids produced by Fatty Acid Synthase (FASN); and cholesterol and
isoprenoids formed through the sequential reactions of many enzymes. The enzymes that mediate acetyl-
transfer reactions often function in the context of multiple domain proteins or multisubunit protein
complexes, which play essential roles in the regulation of cognate substrate recognition and targeting
and/or catalytic fidelity. How the various protein domains and protein cofactors cooperate for their
respective acetyl-transfer reactions remains poorly understood. Correlating with their biological importance,
the aberrant activities of acetyl-transfer enzymes or their regulatory proteins have been associated with
several maladies including cancers, rare genetic disorders, cardiovascular diseases and metabolic and
neurodegenerative syndromes, thus making these enzymes attractive drug targets for therapy. Taken
together, acetyl-transfer reactions play an important regulatory function in the vast majority of the human
proteome, RNAome and metabolome, and aberrant acetyl-transfer reaction function is correlated with
human disease. Despite the importance of acetyl-transfer reactions, mechanistic information regarding
their distinct modes of regulation are poorly understood and pharmacological agents that target them are
not available. In this proposal, we will address the following broad questions underlying acetyl-transfer
reactions: (A) How do protein and RNA acetyltransferases mediate substrate specificity? (B) How do
auxiliary proteins and ribosome association contribute to NAT function? (C) How does acetyl-CoA
metabolism link to chromatin regulation and fatty acid synthesis? (D) Can we leverage mechanistic and
structural information to develop potent and selective inhibitors for acetyl-transfer reactions? Together,
these studies will reveal how a common acetyltransferase fold is modulated by other proteins or domains to
mediate the acetylation of distinct substrates, how N-terminal protein acetylation is modulated by regulatory
and associated factors, dissect the molecular mechanism of essential acetyl-transfer enzymes, and provide
probes to better understand the biology of acetyl-transfer enzymes with clear implications for therapy.
蛋白质和RNA的乙酰化,以及产生细胞代谢产物的乙酰转移反应,
进化上保守的对生命至关重要的修饰。翻译后或翻译共乙酰化
蛋白质为生物体提供了对外部和内部刺激做出反应的基本机制;示例
包括组蛋白对组蛋白赖氨酸侧链的e-氨基的乙酰化
乙酰转移酶(HAT)或N-末端α-氨基通过N-末端乙酰转移酶(NAT),
分别地;和在胞苷碱基的N4位置处通过Nat 10进行乙酰化。乙酰转移反应
产生细胞代谢物,其可以介导必需的细胞构件的生物合成;
实例包括:由ATP-柠檬酸裂解酶(ACLY)和乙酰辅酶A合成酶短-
链家族成员2(ACSS 2);由脂肪酸合酶(FATIGUE)产生的脂肪酸;和胆固醇,
类异戊二烯通过许多酶的连续反应形成。介导乙酰基的酶-
转移反应通常在多结构域蛋白或多亚基蛋白的情况下起作用
复合物,在同源底物识别和靶向调节中发挥重要作用
和/或催化保真度。各种蛋白质结构域和蛋白质辅因子如何合作,
各自的乙酰基转移反应仍然知之甚少。与它们的生物学重要性相关,
乙酰转移酶或其调节蛋白的异常活性与
几种疾病,包括癌症,罕见的遗传性疾病,心血管疾病和代谢和
神经退行性综合征,从而使这些酶成为治疗的有吸引力的药物靶标。采取
总之,乙酰转移反应在绝大多数人的免疫系统中起着重要的调节作用。
蛋白质组、RNA组和代谢组,与异常的乙酰转移反应功能相关
人类疾病尽管乙酰基转移反应的重要性,
它们的不同调节模式知之甚少,靶向它们的药理学试剂
不可用.在这个建议中,我们将讨论以下广泛的乙酰转移问题
反应:(A)蛋白质和RNA乙酰转移酶如何介导底物特异性?(B)怎么
辅助蛋白和核糖体联合有助于NAT功能?(C)乙酰辅酶A
代谢与染色质调节和脂肪酸合成的联系?(D)我们能否利用机械和
结构信息,以开发有效的和选择性的抑制剂乙酰转移反应?在一起,
这些研究将揭示普通乙酰转移酶折叠如何被其他蛋白质或结构域调节,
介导不同底物的乙酰化,调节如何调节N末端蛋白质乙酰化
及相关因素,剖析必需乙酰转移酶的分子机制,并提供
探针,以更好地了解乙酰转移酶的生物学与明确的治疗意义。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
- DOI:10.1158/0008-5472.can-20-3108
- 发表时间:2021-04-01
- 期刊:
- 影响因子:11.2
- 作者:Wolpaw AJ;Bayliss R;Büchel G;Dang CV;Eilers M;Gustafson WC;Hansen GH;Jura N;Knapp S;Lemmon MA;Levens D;Maris JM;Marmorstein R;Metallo SJ;Park JR;Penn LZ;Rape M;Roussel MF;Shokat KM;Tansey WP;Verba KA;Vos SM;Weiss WA;Wolf E;Mossé YP
- 通讯作者:Mossé YP
Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome.
- DOI:10.1038/s41431-023-01368-y
- 发表时间:2023-07
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
The GNU subunit of PNG kinase, the developmental regulator of mRNA translation, binds BIC-C to localize to RNP granules.
- DOI:10.7554/elife.67294
- 发表时间:2021-07-12
- 期刊:
- 影响因子:7.7
- 作者:Avilés-Pagán EE;Hara M;Orr-Weaver TL
- 通讯作者:Orr-Weaver TL
N-alpha-acetylation of Huntingtin protein increases its propensity to aggregate.
- DOI:10.1016/j.jbc.2021.101363
- 发表时间:2021-12
- 期刊:
- 影响因子:0
- 作者:Gottlieb L;Guo L;Shorter J;Marmorstein R
- 通讯作者:Marmorstein R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronen Marmorstein其他文献
Ronen Marmorstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronen Marmorstein', 18)}}的其他基金
Predoctoral Training at the Chemistry-Biology Interface
化学-生物学界面的博士前培训
- 批准号:
10202660 - 财政年份:2020
- 资助金额:
$ 57.88万 - 项目类别:
Predoctoral Training at the Chemistry-Biology Interface
化学-生物学界面的博士前培训
- 批准号:
10417113 - 财政年份:2020
- 资助金额:
$ 57.88万 - 项目类别:
Predoctoral Training at the Chemistry-Biology Interface
化学-生物学界面的博士前培训
- 批准号:
10642840 - 财政年份:2020
- 资助金额:
$ 57.88万 - 项目类别:
Predoctoral Training at the Chemistry-Biology Interface
化学-生物学界面的博士前培训
- 批准号:
10024683 - 财政年份:2020
- 资助金额:
$ 57.88万 - 项目类别:
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
开发 BRAF 二聚体抑制剂来治疗耐药性黑色素瘤
- 批准号:
10058819 - 财政年份:2018
- 资助金额:
$ 57.88万 - 项目类别:
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
开发 BRAF 二聚体抑制剂来治疗耐药性黑色素瘤
- 批准号:
10533742 - 财政年份:2018
- 资助金额:
$ 57.88万 - 项目类别:
Development of BRAF Dimer Inhibitors to Treat Drug Resistant Melanoma
开发 BRAF 二聚体抑制剂来治疗耐药性黑色素瘤
- 批准号:
10317051 - 财政年份:2018
- 资助金额:
$ 57.88万 - 项目类别:
Molecular Mechanisms, Pathways and Inhibition of Acetyl-Transfer Reactions
乙酰基转移反应的分子机制、途径和抑制
- 批准号:
10427241 - 财政年份:2016
- 资助金额:
$ 57.88万 - 项目类别:
Molecular Mechanisms, Pathways and Inhibition of Acetyl-Transfer Reactions
乙酰基转移反应的分子机制、途径和抑制
- 批准号:
10163349 - 财政年份:2016
- 资助金额:
$ 57.88万 - 项目类别:
Molecular Basis for Activity by Membrane Bound O-Acyltransferases
膜结合 O-酰基转移酶活性的分子基础
- 批准号:
9231362 - 财政年份:2016
- 资助金额:
$ 57.88万 - 项目类别:














{{item.name}}会员




